Amar N Patel, DO | |
9205 Legacy Dr, Frisco, TX 75033-6750 | |
(972) 668-6020 | |
Not Available |
Full Name | Amar N Patel |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Experience | 15 Years |
Location | 9205 Legacy Dr, Frisco, Texas |
Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073808846 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | BP10035532 (Texas) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Legacy Urgent Care Pa | 3072679828 | 119 |
News Archive
Genticel, a French biotechnology company and developer of innovative immunotherapies to prevent cancers caused by the human papillomavirus, today announces that the US Food and Drug Administration (FDA) has cleared Genticel's Investigational New Drug application to conduct in the US a phase 1 clinical study of GTL001 in patients infected with HPV 16 and/or 18, the two HPV types responsible for 70% of cervical cancer cases.
Researchers at the University of California, San Diego School of Medicine have identified the motors that move non-infectious prion proteins (PrPC) - found within many mammalian cells - up and down long, neuronal transport pathways.
In a two-day conference organised in collaboration between the Maltese Presidency of the Council of the European Union and ECDC, HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
Stem cells from adult schizophrenia patients form new proteins more slowly than those from healthy people, according to new research.
› Verified 8 days ago
Entity Name | Legacy Urgent Care Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1568622272 PECOS PAC ID: 3072679828 Enrollment ID: O20090304000140 |
News Archive
Genticel, a French biotechnology company and developer of innovative immunotherapies to prevent cancers caused by the human papillomavirus, today announces that the US Food and Drug Administration (FDA) has cleared Genticel's Investigational New Drug application to conduct in the US a phase 1 clinical study of GTL001 in patients infected with HPV 16 and/or 18, the two HPV types responsible for 70% of cervical cancer cases.
Researchers at the University of California, San Diego School of Medicine have identified the motors that move non-infectious prion proteins (PrPC) - found within many mammalian cells - up and down long, neuronal transport pathways.
In a two-day conference organised in collaboration between the Maltese Presidency of the Council of the European Union and ECDC, HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
Stem cells from adult schizophrenia patients form new proteins more slowly than those from healthy people, according to new research.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Amar N Patel, DO 6807 Cheswick Ct, Parker, TX 75002-3027 Ph: (817) 845-1663 | Amar N Patel, DO 9205 Legacy Dr, Frisco, TX 75033-6750 Ph: (972) 668-6020 |
News Archive
Genticel, a French biotechnology company and developer of innovative immunotherapies to prevent cancers caused by the human papillomavirus, today announces that the US Food and Drug Administration (FDA) has cleared Genticel's Investigational New Drug application to conduct in the US a phase 1 clinical study of GTL001 in patients infected with HPV 16 and/or 18, the two HPV types responsible for 70% of cervical cancer cases.
Researchers at the University of California, San Diego School of Medicine have identified the motors that move non-infectious prion proteins (PrPC) - found within many mammalian cells - up and down long, neuronal transport pathways.
In a two-day conference organised in collaboration between the Maltese Presidency of the Council of the European Union and ECDC, HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
Stem cells from adult schizophrenia patients form new proteins more slowly than those from healthy people, according to new research.
› Verified 8 days ago
Christina Holtz, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 5858 W Main St Ste 130, Frisco, TX 75033 Phone: 214-387-4073 Fax: 214-387-8395 | |
Brett Donahey, DO Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 7000 Parkwood Blvd Ste B200, Frisco, TX 75034 Phone: 214-705-1900 | |
Mohita Anil Patel, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 9255 Dallas Pkwy Ste 110, Frisco, TX 75033 Phone: 972-377-1490 Fax: 972-377-1499 | |
Dr. Bradley Ryan Friedman, M.D. Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 11560 Teel Pkwy, Suite #100, Frisco, TX 75034 Phone: 972-668-0821 | |
Avneet Kaur Bajwa, FNP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5350 Independence Pkwy Ste 120, Frisco, TX 75035 Phone: 214-888-2244 | |
Amylie Rojas, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 4461 Coit Rd Ste 301, Frisco, TX 75035 Phone: 469-800-6120 |